16/12/2020 – AB Science will host a live webcast on December 17, 2020 on masitinib results in Alzheimer’s Disease Download PDF Category: 2020By Alexis BERNARD16 December 2020Tags: webcast Partager cet article Share on LinkedInShare on LinkedIn Share on XShare on X Share on FacebookShare on Facebook Share on WhatsAppShare on WhatsApp Pin itShare on Pinterest Author: Alexis BERNARD Post navigationPreviousPrevious post:Positive Phase 2/3 study AB09004 with masitinib in Alzheimer’s DiseaseNextNext post:Corrective press release regarding adverse events information from study AB09004Related PostsBoursorama interview of Alain Moussy, CEO of AB Science23 December 2020Capital raise for a total amount of 15 million euros21 December 2020Results from phase 2B/3 study evaluating masitinib in Alzheimer’s disease18 December 2020Masitinib in Alzheimer’s Disease Webcast Presentation17 December 2020Results of the Extraordinary General Shareholders’ Meeting of December 16, 202017 December 2020Corrective press release regarding adverse events information from study AB0900417 December 2020
